Charles Schwab Corporation
SCHW
$97.96
+1.30%
The Charles Schwab Corporation is a leading US retail-oriented financial services firm operating across brokerage, banking, asset management, custody, and wealth management, with $11.9 trillion in client assets as of end-2025 and a dominant 40%+ share of the Registered Investment Advisor (RIA) custody market. Unlike pure-play brokers, Schwab monetizes client cash through its bank balance sheet and asset management arm, which generate the majority of revenue and profits, giving it a distinct bank-like earnings profile within the capital markets industry. The current investor narrative centers on the trajectory of net interest margin as the Federal Reserve pivots to its first rate hike since 2023, which could widen spreads and boost bank segment earnings, while simultaneously pressuring client cash sorting dynamics. Management is also pushing into wealth management via robo-advisory and direct indexing, and the stock has become a debate between rate-cycle beneficiaries and those worried about decelerating organic growth and competitive pressure from Robinhood and Interactive Brokers.…
SCHW
Charles Schwab Corporation
$97.96
Related headlines
Investment Opinion: Should I buy SCHW Today?
The synthesized recommendation is Hold, with a bias toward accumulation on weakness. The core thesis is that Schwab's 24.97% revenue growth and 32.87% net margin are impressive, but the stock's premium valuation and recent 10.66% one-month decline suggest the market is questioning the durability of rate-driven earnings. The analyst consensus rating of Buy with an average target price of $124.19 implies 28.4% upside, but the wide target range of $91 to $145 and the recent BMO downgrade indicate divided sentiment.
Supporting evidence includes the forward PE of 12.35x versus trailing PE of 21.35x, implying significant earnings growth, and the PEG ratio of 0.381, which suggests undervaluation relative to growth. Revenue grew 24.97% year-over-year in Q2 2026, net margin expanded to 32.87% from 31.19% a year earlier, and ROE of 17.91% exceeds many peers. However, free cash flow is volatile, with negative operating cash flow in Q2 2026, and the PB ratio of 3.58x is near the upper end of its historical range, limiting margin of safety.
The biggest risks that could invalidate the thesis are a deceleration in revenue growth below 15%, a compression in net interest margin if the Fed pauses rate hikes, and competitive share loss to Robinhood and Interactive Brokers. The rating would upgrade to Buy if the stock pulls back to the analyst low target of $91 or if forward PE compresses below 12x with sustained revenue growth above 20%. It would downgrade to Sell if revenue growth falls below 10% or if net margin drops below 25%. Relative to its history and peers, the stock appears fairly valued to slightly overvalued, trading at a premium to the capital markets average but with superior profitability.
Sign up to view all
SCHW 12-Month Price Forecast
Schwab presents a balanced risk/reward profile with a neutral stance. The company's 24.97% revenue growth and 32.87% net margin are impressive, and the forward PE of 12.35x suggests the market expects a substantial earnings rebound. However, the stock's premium valuation relative to peers, volatile free cash flow, and recent underperformance versus the market warrant caution. The analyst consensus target of $124.19 implies 28.4% upside, but the wide target range and BMO downgrade highlight uncertainty. I would upgrade to bullish if revenue growth sustains above 20% for two more quarters and net interest margin expands, or downgrade to bearish if revenue growth falls below 15% or net margin drops below 28%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Charles Schwab Corporation's 12-month outlook, with a consensus price target around $123.29 and implied upside of +25.9% versus the current price.
Average Target
$123.29
0 analysts
Implied Upside
+25.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$91 - $145
Analyst target range
Schwab is covered by 21 analysts with a consensus recommendation of "Buy" (mean rating of 1.78 on a 1-5 scale where 1 is Strong Buy), and the average target price of $124.19 implies +28.4% upside from the current price of $96.70. The consensus leans bullish, with recent ratings from Morgan Stanley (Overweight), Barclays (Overweight), UBS (Buy), and Argus Research (Buy) reinforcing the positive stance, though BMO Capital downgraded to Market Perform from Outperform in July 2026, signaling some caution. The estimated EPS average of $10.25 for the forward year supports the bullish case, but the stock's recent 10.66% one-month decline suggests the market is not yet pricing in that optimism.
The target range spans from a low of $91.00 to a high of $145.00, a wide spread of 59% that signals high uncertainty about the company's trajectory. The high target of $145 assumes successful margin expansion from the Fed's rate hike cycle, accelerating organic growth, and multiple expansion toward historical peaks, while the low target of $91 prices in margin compression, competitive share loss to Robinhood and Interactive Brokers, and a potential recession impacting client cash balances. The wide spread, combined with the recent downgrade from BMO Capital, suggests analysts are divided on whether the rate-driven earnings boost is sustainable, and the stock's low beta of 0.753 may attract risk-averse investors despite the near-term headwinds.
Bulls vs Bears: SCHW Investment Factors
The bear case currently has stronger near-term evidence, given the stock's 10.66% one-month decline, -11.25 percentage point relative underperformance versus SPY, and a premium valuation with limited margin of safety. However, the bull case rests on a powerful forward earnings rebound implied by the 12.35x forward PE and $10.25 EPS estimate, which would justify the current price if achieved. The single most important tension is whether the 24.97% revenue growth is durable fee-based expansion or transient rate-driven income; if it proves durable, the stock is undervalued, but if it fades, multiple compression toward the historical low of 14.88x PE could be severe. The wide analyst target spread of $91 to $145 encapsulates this binary debate, and the recent BMO downgrade suggests the market is not yet convinced the growth is sustainable.
Bullish
- Revenue growth accelerating sharply: Q2 2026 revenue of $8.518 billion grew 24.97% year-over-year versus $6.816 billion in Q2 2025, with sequential gains from $7.168 billion in Q4 2025 to $7.3 billion in Q1 2026. This acceleration supports a re-rating case if the growth proves durable rather than purely rate-driven.
- Forward PE implies massive earnings rebound: The stock trades at a trailing PE of 21.35x but a forward PE of just 12.35x, with forward EPS estimates of $10.25 versus trailing EPS of roughly $4.53 annualized. This wide gap suggests analysts expect a substantial profitability rebound, and the PEG ratio of 0.381 is well below 1.0.
- Analyst consensus sees 28% upside: 21 analysts rate the stock a Buy with a mean rating of 1.78 and an average target price of $124.19, implying +28.4% upside from the current $96.70. Recent ratings from Morgan Stanley (Overweight), Barclays (Overweight), UBS (Buy), and Argus Research (Buy) reinforce the bullish stance.
- Best-in-class margins and returns: Net margin of 32.87% in Q2 2026 is well above the capital markets industry typical range of 15-25%, while ROE of 17.91% and ROA of 2.07% are healthy for a financial institution. Operating margin of 43.07% and gross margin of 83.02% underscore Schwab's scale advantages.
Bearish
- Severe recent underperformance vs. market: The stock has declined 10.66% over the past month while SPY gained 0.59%, resulting in a relative strength of -11.25 percentage points. The 1-year relative strength of -10.70% and YTD relative strength of -17.65% show persistent underperformance despite positive absolute returns.
- Premium valuation with limited margin of safety: The trailing PE of 21.35x is above the typical capital markets average of 15-18x, representing a 20-40% premium, while the PB ratio of 3.58x is near the upper end of its historical range (2.39x to 4.24x). The PS ratio of 6.40x and EV/EBITDA of 12.63x suggest the market is pricing in continued growth.
- Volatile and negative free cash flow: Quarterly free cash flow swung from -$2.969 billion in Q2 2026 to +$7.202 billion in Q1 2026, largely due to working capital and client cash movements. The negative operating cash flow in Q2 2026 warrants watching, and the current ratio of 0.530 reflects the bank-like structure where current liabilities include client cash balances.
- Competitive pressure from digital brokers: Robinhood now runs 13 revenue lines above $100 million a year, and Interactive Brokers grew customer accounts 34% in a year, signaling intensifying competition for retail brokerage share. Schwab's recent 10.66% one-month decline may partly reflect concerns about organic growth deceleration.
SCHW Technical Analysis
Schwab is in a choppy, range-bound consolidation with a modest upward tilt over the past year, posting a 1-year price change of +4.32% while trading at 96.7, which sits at roughly 41.6% of its 52-week range (low of 83.96, high of 114.53). That positioning is neither near breakout highs nor deeply oversold lows, suggesting the market is in a wait-and-see mode rather than a momentum chase or capitulation. The stock has spent the past six months oscillating between the high 80s and low 110s, with the 6-month change of +3.12% confirming a slow grind higher rather than a sustained trend.
Recent momentum has deteriorated sharply, with a 1-month decline of -10.66% and a 3-month change of just -0.31%, diverging negatively from the positive 1-year trend. This divergence signals a loss of near-term conviction, likely driven by the Fed's September rate hike and rotation out of financials, and the relative strength versus SPY over the past month is -11.25 percentage points, a stark underperformance. The 3-month relative strength of -3.65% is less severe, indicating the weakness is concentrated in the most recent weeks rather than a prolonged downtrend.
Key technical support sits at the 52-week low of 83.96, roughly 13% below the current price, while resistance is anchored at the 52-week high of 114.53, about 18% above. A breakout above 114.53 would signal renewed institutional accumulation and likely require a catalyst such as margin expansion or strong Q3 earnings, while a breakdown below 83.96 would confirm a deeper bearish trend and could trigger momentum-driven selling. With a beta of 0.753, Schwab is roughly 25% less volatile than the broader market, meaning position sizing can be larger for equivalent risk exposure, though the recent -20.39% max drawdown shows the stock is not immune to sharp corrections.
Beta
0.78
0.78x market volatility
Max Drawdown
-20.4%
Largest decline past year
52-Week Range
$84-$115
Price range past year
Annual Return
+4.1%
Cumulative gain past year
| Period | SCHW Return | S&P 500 |
|---|---|---|
| 1m | -10.4% | +0.6% |
| 3m | -3.9% | +3.6% |
| 6m | +1.3% | +14.6% |
| 1y | +4.1% | +15.8% |
| ytd | -3.6% | +13.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCHW Fundamental Analysis
Schwab's revenue trajectory is clearly accelerating, with Q2 2026 revenue of $8.518 billion representing 24.97% year-over-year growth versus Q2 2025's $6.816 billion, and the multi-quarter trend shows steady sequential gains from $7.168 billion in Q4 2025 to $7.3 billion in Q1 2026 to $8.518 billion in Q2 2026. The Investor Services segment generated $9.919 billion while Advisor Services contributed $2.552 billion, indicating that the retail brokerage and banking franchise remains the primary growth engine. This acceleration, if sustained, supports a re-rating case, but the market will scrutinize whether the growth is rate-driven (potentially transient) or fee-based (more durable).
Profitability is robust, with Q2 2026 net income of $2.8 billion and a net margin of 32.87%, up from 31.19% in Q2 2025, while gross margin stands at 83.02% and operating margin at 43.07%. The net income ratio has expanded from 28.71% in Q1 2025 to 32.87% in Q2 2026, reflecting operating leverage as revenue grows faster than expenses. These margins are strong for the capital markets industry, where net margins typically range from 15-25%, underscoring Schwab's scale advantages and the high-margin nature of its asset management and bank segments.
Balance sheet health is solid but requires monitoring, with a debt-to-equity ratio of 0.626 and a current ratio of 0.530, the latter reflecting the bank-like structure where current liabilities include client cash balances. Free cash flow on a TTM basis is $3.705 billion, though quarterly FCF has been volatile, swinging from -$2.969 billion in Q2 2026 to +$7.202 billion in Q1 2026, largely due to working capital and client cash movements. ROE of 17.91% and ROA of 2.07% are healthy for a financial institution, and the dividend payout ratio of 26.31% with a 1.32% yield suggests ample capacity for continued capital return, though the negative operating cash flow in Q2 2026 warrants watching.
Quarterly Revenue
$8.5B
2026-06
Revenue YoY Growth
+25.0%
YoY Comparison
Gross Margin
83.0%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCHW Overvalued?
Because Schwab is profitable with positive net income of $2.8 billion in Q2 2026, the PE ratio is the primary valuation metric, and the stock trades at a trailing PE of 21.35x versus a forward PE of 12.35x. This wide gap implies the market expects significant earnings growth, with forward EPS estimates of $10.25 versus trailing EPS of roughly $4.53 (based on the reported quarterly EPS of $1.55 annualized), suggesting analysts anticipate a substantial rebound in profitability. The PEG ratio of 0.381 is well below 1.0, which on the surface suggests undervaluation relative to growth, though this metric can be distorted for financials.
Relative to the broader financial services sector, Schwab's PE of 21.35x is above the typical capital markets average of 15-18x, representing a premium of roughly 20-40%, while its PB ratio of 3.58x is elevated versus the sector's typical 1.5-2.5x range. This premium is partially justified by Schwab's 32.87% net margin and 17.91% ROE, which exceed many peers, but the PS ratio of 6.40x and EV/EBITDA of 12.63x suggest the market is pricing in continued growth. The premium may compress if revenue growth decelerates or if rate-driven earnings prove less durable than expected.
Historically, Schwab's PE has ranged from a low of 14.88x in Q2 2026 to a high of 33.73x in Q4 2023, with the current 21.35x sitting in the middle of that band. The PB ratio of 3.58x is near the upper end of its historical range (2.39x to 4.24x), indicating the market is pricing in optimistic expectations relative to book value. This mid-to-upper valuation positioning suggests limited margin of safety, and any earnings miss or macro headwind could trigger multiple compression toward the lower end of the historical range.
PE
21.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 15x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple
Investment Risk Disclosure
Schwab's financial risks center on the volatility of its bank-like balance sheet and cash flow generation. Quarterly free cash flow swung from -$2.969 billion in Q2 2026 to +$7.202 billion in Q1 2026, a $10.17 billion swing driven by working capital and client cash movements, making cash flow forecasting difficult. The current ratio of 0.530 reflects a structure where current liabilities include client cash balances, and while the debt-to-equity ratio of 0.626 is manageable, the negative operating cash flow in Q2 2026 warrants close monitoring. Additionally, the company's revenue is heavily concentrated in net interest income from client cash, which is sensitive to rate changes and client cash sorting behavior.
Market and competitive risks are significant given Schwab's premium valuation and intensifying competition. The trailing PE of 21.35x is above the typical capital markets average of 15-18x, and the PB ratio of 3.58x is near the upper end of its historical range, leaving limited margin of safety if growth decelerates. Robinhood's rapid product diversification and Interactive Brokers' 34% account growth highlight competitive threats to Schwab's retail brokerage franchise. With a beta of 0.753, the stock is less volatile than the market, but the recent -10.66% one-month decline and -11.25 percentage point relative underperformance versus SPY show it is not immune to sector rotation or macro headwinds, especially as the Fed's first rate hike since 2023 could pressure growth stock multiples.
The worst-case scenario would involve a combination of margin compression, competitive share loss, and a recession impacting client cash balances. In this scenario, the stock could retest its 52-week low of $83.96, representing a 13.2% decline from the current price of $96.70, or fall to the analyst low target of $91.00, a 5.9% decline. A more severe outcome, such as a recession-driven earnings miss and multiple compression toward the historical low PE of 14.88x, could push the stock below $80, implying a loss of 17% or more. The max drawdown of -20.39% over the past year shows that sharp corrections are possible, and investors could lose 13-20% from current levels in an adverse scenario.
FAQ
The most severe risk is financial: volatile free cash flow, with quarterly FCF swinging from -$2.969 billion in Q2 2026 to +$7.202 billion in Q1 2026, and a current ratio of 0.530 reflecting a bank-like balance sheet. Competitive risk is rising, with Robinhood running 13 revenue lines above $100 million and Interactive Brokers growing accounts 34% in a year, threatening Schwab's retail brokerage share. Macro risk includes the Fed's first rate hike since 2023, which could pressure growth stock multiples and client cash balances, as evidenced by the stock's -10.66% one-month decline and -11.25 percentage point relative underperformance versus SPY. Company-specific risk includes the recent BMO Capital downgrade to Market Perform and a wide analyst target spread of $91 to $145, indicating uncertainty about earnings sustainability.
The 12-month forecast has three scenarios: a bull case with 30% probability targeting $124-$145, a base case with 50% probability targeting $110-$124, and a bear case with 20% probability targeting $83.96-$91. The base case is most likely, assuming revenue growth decelerates to 15-20% but remains healthy, net margin holds around 30-32%, and forward EPS of $10.25 is achieved, supporting a 12x forward PE. The key assumption behind the base case is that rate-driven income stabilizes without a sharp contraction and competitive pressures do not materially erode market share. The bull case requires additional rate hikes and successful wealth management expansion, while the bear case assumes revenue growth falls below 10% and margin compression.
SCHW appears fairly valued to slightly overvalued on trailing metrics, with a PE of 21.35x versus the capital markets average of 15-18x, and a PB ratio of 3.58x near the upper end of its historical range of 2.39x to 4.24x. However, the forward PE of 12.35x and PEG ratio of 0.381 suggest undervaluation relative to expected growth, implying the market is pricing in a substantial earnings rebound to $10.25 per share. The PS ratio of 6.40x and EV/EBITDA of 12.63x indicate the market expects continued revenue growth and margin expansion. If the earnings rebound materializes, the stock is undervalued; if growth disappoints, the premium could compress toward the historical low PE of 14.88x.
From a risk/reward perspective, SCHW offers 28.4% upside to the analyst average target of $124.19, but the downside risk to the 52-week low of $83.96 is 13.2%, and to the analyst low target of $91.00 is 5.9%. The stock trades at a trailing PE of 21.35x, a premium to the capital markets average of 15-18x, but a forward PE of 12.35x suggests significant earnings growth is expected. The biggest downside risk is a deceleration in revenue growth or margin compression if rate-driven income fades. For long-term investors with a 2-3 year horizon, the stock is a reasonable buy on weakness, especially near the $91 support level, but near-term headwinds and premium valuation make it less attractive for short-term trading.
SCHW is better suited for long-term investment given its beta of 0.753, which indicates lower volatility than the market, and its 1.32% dividend yield with a conservative payout ratio of 26.31%. The company is in a mature growth stage with $11.9 trillion in client assets and a dominant 40%+ share of the RIA custody market, providing stable earnings visibility over multi-year periods. Short-term trading is less attractive due to the stock's recent 10.66% one-month decline and choppy range-bound technicals, with support at $83.96 and resistance at $114.53. A suggested minimum holding period is 2-3 years to allow the rate cycle and wealth management initiatives to play out, capturing the expected earnings rebound and potential multiple expansion.